Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition.

Oncotarget · 2016 · PMC4891137 · PMID 26859680

Europe PMC DOI

hedged sentence

0.2930

closest p · 5.9× alpha

0.2930

boldest claim

The sentences

did not reach statistical significancep = 0.293not close (p > 0.1)

Remarkably, Trast-NG/DOX + 17AAG treatment led to an actual reduction in tumor volume (shrinkage) compared to the pre-treatment tumor volume, clearly observed at later time points (Figure 5A ), although this difference did not reach statistical significance ( p = 0.293).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.